David M. Berman, HEAD OF R&D at Immunocore Holdings plc (IMCR), sold 123,698 shares at $35.23 ($4.4M) on 2025-09-30, disclosed to the SEC on 2025-10-02.
Scheduled sale ($4.4M) by HEAD OF R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.23 | 61,849 | $2.2M | 50.0% |
| 2 | $35.23 | 61,849 | $2.2M | 50.0% |
| Total | $35.23 avg | 123,698 | $4.4M | 100% |
| Filing → |
| IMCR | SELL | 2025-12-01 | $6.0M | — | Filing → |
| IMCR | SELL | 2025-11-26 | $1.4M | — | Filing → |
| IMCR | SELL | 2025-09-16 | $1.6M | — | Filing → |